explore -WSS

explore

author：entertainment 2025-09-29 20:52:41 - browse：5518

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

knowledge

WSS

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

In 'major milestone,' FDA approves first cell therapy for solid tumors

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

HIV drugs protect against transmission, even in unprotected sex

Wikipedia

explore

explore

Sports medicine is finally prioritizing gender equality

Congress may force more Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Abridge raises $150m as clinical notes automation market heats up

Alkermes shareholders re

BMI, flaws aside, is found to be useful estimate of body fat in youth

Cancer drug shortages should be causing more outrage

HIV drugs protect against transmission, even in unprotected sex

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

knowledge

Shifting the focus from loneliness to social health

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Ultragenyx gene therapy for rare liver ailment succeeds in late

Abridge raises $150m as clinical notes automation market heats up

Hospitals are piloting generative AI tools as regulators play catch

Weight loss drugs aren’t covered by Obamacare. That may change

focus

focus

knowledge

explore